Why Small Biotech Stocks Top List of Potential Outperformers this Fall (GTHX, ATRX, SRPT, MGNX, CPRX, CLDX, BDSI, SAVA)

The smaller cap biotech space offers two key advantages for investors right now: cyclical diversification and diversification away from the vaccine monolithic theme. To break that down a bit, the stock market has been volatile over the past month, with many growth plays getting smacked down as risk comes off the table with Wall Street […]

Sarepta Therapeutics’ Eteplirsen Study Reveals Benefits to Patients (SRPT)

Sarepta Therapeutics (NASDAQ: SRPT), an RNA-based therapeutics company that develops drugs to treat serious, life-threatening, rare and infectious diseases, announced at the Action Duchenne meeting in London that patients treated with eteplirsen continue to do well. Benefits to Patients Sarepta’s Chief Medical Officer, Dr. Ed Kaye, was speaking about the results from the phase II […]